Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Rare Cancer Drug Development, NCI Trials

Alice Chen

MD

🏢National Cancer Institute (NCI)🌐USA

Head, Investigational Drug Branch

36
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Alice Chen leads the Investigational Drug Branch at NCI, overseeing development of novel therapeutics for rare and common cancers through NCI-sponsored trials. She has been centrally involved in the NCI-MATCH precision medicine trial that evaluates molecularly targeted therapies across rare cancer subtypes. Her work advances access to novel therapeutics for patients with rare malignancies through the NCI clinical trials network.

Share:

🧪Research Fields 研究领域

NCI rare cancer trials
MATCH trial rare subtypes
rare tumor molecular targeting
pediatric rare cancers
basket trial rare histologies

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Alice Chen 的研究动态

Follow Alice Chen's research updates

留下邮箱,当我们发布与 Alice Chen(National Cancer Institute (NCI))相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment